Infant ibuprofen unfailing to be sold at several inhabitant retailers competence enclose a higher concentration of ibuprofen, heading to intensity risks in infants, according to a Wednesday intentional remember notice.
New Jersey-based Tris Pharma, Inc. said lots sole underneath Walmart, CVS Pharmacy and Family Dollar brands are impacted by a recall. The products were labeled to contain 50 mg of Ibuprofen per 1.25 mL.
The association pronounced there is a “remote possibility” a increasing volume of ibuprofen could lead to permanent kidney damage in infants. Other inauspicious effects could embody nausea, vomiting, stomach pain and diarrhea, along with tinnitus, headaches or probable stomach bleeding.
To date, a association says it has not perceived any reports of inauspicious events associated to a recall.
Tris Pharma says the influenced lots of ibuprofen were sole to a patron that distributes a drug to retailers. Retailers and wholesalers of a product have been told to stop serve placement of a effected lots.
Intended for use as a pain reliever and heat reducer, a product was finished in 0.5 oz. bottles and labeled “Infants’ Ibuprofen Concentrated Oral Suspension.”
Walmart sells a product underneath the “Equate” label; CVS sells it underneath a “CVS Health” tag and Family Dollar sells it underneath a “Family Wellness” label.
The release does not mention that states perceived a product.
The impacted products bear lot numbers 00717009A, 00717015A, 00717024A from Walmart; 00717024A from CVS; and 00717024A from Family Dollar.
The packages are labeled with NDC (National Drug Code) numbers of 49035-125-23 from Walmart, 59779-925-23 from CVS and 55319-250-23 from Family Dollar.
More information about a remember is accessible from a company’s release.
Contributing: The Arizona Republic, azcentral.com.